DiaMedica Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Minneapolis, MN
SEC filing record 1 source field available
Fiscal year end
31 December
DiaMedica Therapeutics Inc. has filed 423 SEC EDGAR filings since 16 May 2007

SEC filing history

Showing 176-200 of 422 matching filings.

Per page
25
Current page
8
D File 021-479300

D filing

Filing date
18 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Apr 2023
Reporting date
10 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
11 Apr 2023
Reporting date
10 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36291

ARS filing

Filing date
04 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36291

FORM DEFA14A

Filing date
04 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36291

FORM DEF 14A

Filing date
04 Apr 2023
Reporting date
17 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36291

FORM PRE 14A

Filing date
17 Mar 2023
Reporting date
17 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36291

FORM 8-K/A

Filing date
10 Mar 2023
Reporting date
01 Mar 2023
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
06 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90788

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90788

SC 13G/A

Filing date
13 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Dec 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Dec 2022
Reporting date
06 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90788

SCHEDULE 13G

Filing date
06 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Dec 2022
Reporting date
02 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .